Información de la droga para SULFAMETHOXAZOLE AND TRIMETHOPRIM ORAL SUSPENSION, USP (CHERRY FLAVOR) and SULFAMETHOXAZOLE AND TRIMETHOPRIM ORAL SUSPENSION, USP (GRAPE FLAVOR) 200 mg/40 mg per 5 mL (Qualitest Pharmaceuticals): REFERENCES

Ads
    • Kremers P, Duvivier J, Heusghem C. Pharmacokinetic studies of co-trimoxazole in man after single and repeated doses. J Clin Pharmacol. 1974;14:112–117.
    • Kaplan SA, Weinfeld RE, Abruzzo CW, McFaden K, Jack ML, Weissman L. Pharmacokinetic profile of trimethoprim-sulfamethoxazole in man. J Infect Dis. 1973;128(suppl):S547–S555.
    • Varoqaux O, et al. Pharmacokinetics of the trimethoprimsulfamethoxazole combination in the elderly. Br J Clin Pharmacol. 1985; 20: 575–581.
    • Antibiotic susceptibility discs; certification procedure. Federal Register. 1972;37:20527–20529.
    • Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by standardized single disk method. Am J Clin Pathol. 1966;45:493–496.
    • Brumfitt W, Pursell R. Trimethoprim-sulfamethoxazole in the treatment of bacteriuria in women. J Infect Dis. 1973;128(suppl):S657–S663.
    • Marinella MA. Trimethoprim-induced hyperkalemia: An analysis of reported cases. Gerontology 45: 209–212, 1999.
  • Drug Information Provided by National Library of Medicine (NLM).
Ads